keyword
https://read.qxmd.com/read/38621608/impact-of-radiation-therapy-modalities-on-loco-regional-control-in-inflammatory-breast-cancer
#21
JOURNAL ARTICLE
Maximilien Rogé, Youlia Kirova, Emilie Lévêque, Marin Guigo, Alison Johnson, Rafik Nebbache, Eleonor Rivin Del Campo, Ioana Lazarescu, Stéphanie Servagi, Augustin Mervoyer, Axel Cailleteau, Sébastien Thureau, Juliette Thariat
INTRODUCTION: In inflammatory breast cancer (IBC), radiotherapy intensification is considered a standard of care by some teams, although the level of evidence remains low. We sought to analyze the impact of radiotherapy modalities on the risk of loco-regional and distant relapse. METHODS: A retrospective multicenter study included patients with localized IBC treated between 2010 and 2017. Standard post-mastectomy radiotherapy consisted of daily fractions to a total dose of 50 Gy equivalent without a boost or bolus, while intensified radiotherapy referred to the use of a boost or bolus...
April 13, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38618474/novel-insights-into-the-epidemiological-and-clinico-pathological-profile-of-triple-negative-breast-cancer-dissection-of-an-aggressive-variant
#22
JOURNAL ARTICLE
Vijay Sai Reddy M, Varsha Viswambharan, Varun Shetty, Sarthak Sharma
Objective Triple-negative breast cancer (TNBC) represents an aggressive and prognostically poor variant of breast cancer. Over the years, detailed research has been conducted and published in Western literature. However, there lacks a detailed account of TNBC cases from the perspective of a low-volume institution. This study aims to assess the clinical features of TNBC, as well as their prognostic implications in a tertiary care centre. Methods and materials This prospective observational study took place at a tertiary health centre for two years, spanning from 2021 to 2023...
March 2024: Curēus
https://read.qxmd.com/read/38618243/enhancing-metformin-induced-tumor-metabolism-destruction-by-glucose-oxidase-for-triple-combination-therapy
#23
JOURNAL ARTICLE
Rangrang Fan, Linrui Cai, Hao Liu, Hongxu Chen, Caili Chen, Gang Guo, Jianguo Xu
Despite decades of laboratory and clinical trials, breast cancer remains the main cause of cancer-related disease burden in women. Considering the metabolism destruction effect of metformin (Met) and cancer cell starvation induced by glucose oxidase (GOx), after their efficient delivery to tumor sites, GOx and Met may consume a large amount of glucose and produce sufficient hydrogen peroxide in situ . Herein, a pH-responsive epigallocatechin gallate (EGCG)-conjugated low-molecular-weight chitosan (LC-EGCG, LE) nanoparticle (Met-GOx/Fe@LE NPs) was constructed...
March 2024: Journal of Pharmaceutical Analysis
https://read.qxmd.com/read/38617163/the-application-value-of-a-vendor-specific-deep-learning-image-reconstruction-algorithm-in-triple-low-head-and-neck-computed-tomography-angiography
#24
JOURNAL ARTICLE
Qiushuang Zhang, Youyou Lin, Hailun Zhang, Jianrong Ding, Jingli Pan, Shuai Zhang
BACKGROUND: Head and neck computed tomography angiography (CTA) technology has become the noninvasive imaging method of choice for the diagnosis and long-term follow-up of vascular lesions of the head and neck. However, issues of radiation safety and contrast nephropathy associated with CTA examinations remain concerns. In recent years, deep learning image reconstruction (DLIR) algorithms have been increasingly used in clinical studies, demonstrating their potential for dose optimization...
April 3, 2024: Quantitative Imaging in Medicine and Surgery
https://read.qxmd.com/read/38615223/acute-myocardial-infarction-in-women-a-study-on-risk-factors-angiographic-features-and-outcomes
#25
JOURNAL ARTICLE
Prabha Chapagain Koirala, Ram Kishor Sah, Kunjang Sherpa, Samir Poudyal, Binayak Gautam, Richa Koirala
BACKGROUND: Women with acute coronary syndrome are more likely to have cardiovascular disease risk factors and atypical symptoms as compared to men. In Nepal, there is a rising trend of Coronary Artery Disease and myocardial infarction in women. However, research on acute myocardial infarction in women is lacking. The aim of this study was to study the cardiac risk factors, clinical features, angiographic features, and outcome of acute myocardial infarction in Nepalese women admitted to Hospital...
March 22, 2024: Journal of Nepal Health Research Council
https://read.qxmd.com/read/38614325/prenatal-organophosphate-esters-exposure-and-neurodevelopment-trajectory-in-infancy-evidence-from-the-shanghai-maternal-child-pairs-cohort
#26
JOURNAL ARTICLE
Yuhan Zhou, Liyi Zhang, Pengpeng Wang, Qiang Li, Jinhong Li, Hang Wang, Yuyan Gui, Yang Liu, Xinyao Sui, Jiufeng Li, Huijing Shi, Yunhui Zhang
BACKGROUND: Concerns remain about the neurotoxic properties of the ubiquitous organophosphate esters (OPEs), the replacement of the toxicant polybrominated diphenyl ethers. OBJECTIVES: We examined the associations of prenatal exposure to OPEs and their mixtures with early-life neurodevelopment trajectories. METHODS: Totally 1276 mother-child pairs were recruited from the Shanghai Maternal-Child Pairs Cohort. A high-performance liquid chromatography-triple quadrupole mass spectrometer was used to measure the levels of 7 OPEs in cord serum...
April 11, 2024: Science of the Total Environment
https://read.qxmd.com/read/38613914/open-questions-current-challenges-and-future-perspectives-in-targeting-human-epidermal-growth-factor-receptor-2-low-breast-cancer
#27
REVIEW
G Curigliano, R Dent, H Earle, S Modi, P Tarantino, G Viale, S M Tolaney
Approximately 60% of traditionally defined human epidermal growth factor receptor 2 (HER2)-negative breast cancers express low levels of HER2 [HER2-low; defined as immunohistochemistry (IHC) 1+ or IHC 2+/in situ hybridization (ISH)-]. HER2-low breast cancers encompass a large percentage of both hormone receptor-positive (up to 85%) and triple-negative (up to 63%) breast cancers. The DESTINY-Breast04 trial established that HER2-low tumors are targetable, leading to the approval of trastuzumab deruxtecan (T-DXd) as the first HER2-directed therapy for the treatment of HER2-low breast cancer in the United States and Europe...
April 12, 2024: ESMO Open
https://read.qxmd.com/read/38611925/3-nantc-a-potent-crotoxin-b-derived-peptide-against-the-triple-negative-mda-mb-231-breast-cancer-cell-line
#28
JOURNAL ARTICLE
Patricia Bezerra, Eduardo F Motti
Breast cancer stands as the most prevalent type of tumor and a significant contributor to cancer-related deaths. Among its various subtypes, triple-negative breast cancer (TNBC) presents the worst prognosis due to its aggressive nature and the absence of effective treatments. Crotoxin, a protein found in the venom of Crotalus genus snakes, has demonstrated notable antitumor activity against aggressive solid tumors. However, its application has been hindered by substantial toxicity in humans. In efforts to address this challenge, Crotoxin B-derived peptides were synthesized and evaluated in vitro for their antitumor potential, leading to the discovery of 3-NAntC...
April 6, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38611109/translational-aspects-in-metaplastic-breast-carcinoma
#29
REVIEW
Elizve Nairoby Barrientos-Toro, Qingqing Ding, Maria Gabriela Raso
Breast cancer is the most common cancer among women. Metaplastic breast carcinoma (MpBC) is a rare, heterogeneous group of invasive breast carcinomas, which are classified as predominantly triple-negative breast carcinomas (TNBCs; HR-negative/HER2-negative). Histologically, MpBC is classified into six subtypes. Two of these are considered low-grade and the others are high-grade. MpBCs seem to be more aggressive, less responsive to neoadjuvant chemotherapy, and have higher rates of chemoresistance than other TNBCs...
April 7, 2024: Cancers
https://read.qxmd.com/read/38611025/targeted-dna-sequencing-of-cutaneous-melanoma-identifies-prognostic-and-predictive-alterations
#30
JOURNAL ARTICLE
Alexandra M Haugh, Robert C Osorio, Rony A Francois, Michael E Tawil, Katy K Tsai, Michael Tetzlaff, Adil Daud, Harish N Vasudevan
BACKGROUND: Cutaneous melanoma (CM) can be molecularly classified into four groups: BRAF mutant, NRAS mutant, NF1 mutant and triple wild-type (TWT) tumors lacking any of these three alterations. In the era of immune checkpoint inhibition (ICI) and targeted molecular therapy, the clinical significance of these groups remains unclear. Here, we integrate targeted DNA sequencing with comprehensive clinical follow-up in CM patients. METHODS: This was a retrospective cohort study that assessed clinical and molecular features from patients with localized or metastatic CM who underwent targeted next-generation sequencing as part of routine clinical care...
March 29, 2024: Cancers
https://read.qxmd.com/read/38610934/tumor-infiltrating-lymphocyte-level-consistently-correlates-with-lower-stiffness-measured-by-shear-wave-elastography-subtype-specific-analysis-of-its-implication-in-breast-cancer
#31
JOURNAL ARTICLE
Na Lae Eun, Soong June Bae, Ji Hyun Youk, Eun Ju Son, Sung Gwe Ahn, Joon Jeong, Jee Hung Kim, Yangkyu Lee, Yoon Jin Cha
Background: We aimed to elucidate the clinical significance of tumor stiffness across breast cancer subtypes and establish its correlation with the tumor-infiltrating lymphocyte (TIL) levels using shear-wave elastography (SWE). Methods: SWE was used to measure tumor stiffness in breast cancer patients from January 2016 to August 2020. The association of tumor stiffness and clinicopathologic parameters, including the TIL levels, was analyzed in three breast cancer subtypes. Results : A total of 803 patients were evaluated...
March 22, 2024: Cancers
https://read.qxmd.com/read/38610647/cholesterol-lowering-strategies-for-cardiovascular-disease-prevention-the-importance-of-intensive-treatment-and-the-simplification-of-medical-therapy
#32
REVIEW
Vincenzo Sucato, Antonella Ortello, Francesco Comparato, Giuseppina Novo, Alfredo Ruggero Galassi
Cardiovascular diseases (CVDs) are a leading global cause of mortality and are primarily driven by atherosclerotic coronary artery disease. Their pathogenesis involves multi-factorial mechanisms, among which low-density lipoprotein (LDL) plays a causative role. Recent ESC/EAS guidelines advocate for a shift toward new risk estimation algorithms that better emphasize non-fatal cardiovascular events, lifetime risk prediction, and tailored pharmacological approaches, including statin + ezetimibe and triple therapy, in specific cases...
March 25, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38609406/evaluating-the-agronomic-efficiency-of-alternative-phosphorus-sources-applied-in-brazilian-tropical-soils
#33
JOURNAL ARTICLE
Lucas Jónatan Rodrigues da Silva, Aline da Silva Sandim, Ana Paula Rodrigues da Silva, Angélica Cristina Fernandes Deus, João Arthur Antonangelo, Leonardo Theodoro Büll
Understanding the efficacy of alternative phosphorus (P) sources in tropical soils is crucial for sustainable farming, addressing resource constraints, mitigating environmental impact, improving crop productivity, and optimizing soil-specific solutions. While the topic holds great importance, current literature falls short in providing thorough, region-specific studies on the effectiveness of alternative P sources in Brazilian tropical soils for maize cultivation. Our aim was to assess the agronomic efficiency of alternative P sources concerning maize crop (Zea mays L...
April 12, 2024: Scientific Reports
https://read.qxmd.com/read/38608921/the-inositol-requiring-enzyme-1-ire1-endoplasmic-reticulum-stress-pathway-promotes-mda-mb-231-cell-survival-and-renewal-in-response-to-the-aryl-ureido-fatty-acid-ctu
#34
JOURNAL ARTICLE
Md Khalilur Rahman, Balasubrahmanyam Umashankar, Hassan Choucair, Kirsi Bourget, Tristan Rawling, Michael Murray
Current treatment options for triple-negative breast cancer (TNBC) are limited to toxic drug combinations of low efficacy. We recently identified an aryl-substituted fatty acid analogue, termed CTU, that effectively killed TNBC cells in vitro and in mouse xenograft models in vivo without producing toxicity. However, there was a residual cell population that survived treatment. The present study evaluated the mechanisms that underlie survival and renewal in CTU-treated MDA-MB-231 TNBC cells. RNA-seq profiling identified several pro-inflammatory signaling pathways that were activated in treated cells...
April 10, 2024: International Journal of Biochemistry & Cell Biology
https://read.qxmd.com/read/38608530/platinum-dose-in-neoadjuvant-therapy-for-triple-negative-breast-cancer-a-systematic-review-and-network-meta-analysis
#35
REVIEW
Fausto Petrelli, Antonio Ghidini, Carmen Rea, Maria Chiara Parati, Karen Borgonovo, Michele Ghidini, Fiorella Ruatta, Alberto Zaniboni, Andrea Luciani, Ornella Garrone, Gianluca Tomasello
INTRODUCTION: There are multiple neoadjuvant regimens, including platinum agents for triple-negative breast cancer (TNBC), each with a different safety profile, outcome, and pathologic complete response rate (pCR%). We performed a systematic review and network meta-analysis to compare the efficacy and safety of different platinum-based neoadjuvant CT treatments for TNBC. METHODS: Bibliographic databases (PubMed, Embase, and Cochrane Library) were searched from their inception to October 31, 2022...
April 11, 2024: Current Problems in Cancer
https://read.qxmd.com/read/38608442/incidence-of-thyroid-dysfunction-caused-by-immune-checkpoint-inhibitors-combined-with-chemotherapy-a-systematic-review-and-meta-analysis
#36
REVIEW
Ping Yang, Guoshuang Shen, Hengheng Zhang, Chengrong Zhang, Jinming Li, Fuxing Zhao, Zitao Li, Zhen Liu, Miaozhou Wang, Jiuda Zhao, Yi Zhao
BACKGROUND: The combination of immune checkpoint inhibitors (ICIs) and chemotherapy as a first-line treatment for triple-negative breast cancer (TNBC) has been associated with many adverse reactions. Thyroid dysfunction, the most common adverse reaction of the endocrine system, has also attracted significant attention. This study aimed to analyse the effect of ICIs combined with chemotherapy on thyroid function in patients with TNBC. METHODS: As of November 4, 2023, we searched the PubMed, Web of Science, and Cochrane Library databases for clinical trials of ICIs combined with chemotherapy for the treatment of TNBC...
April 11, 2024: International Immunopharmacology
https://read.qxmd.com/read/38608322/boosting-predictive-models-and-augmenting-patient-data-with-relevant-genomic-and-pathway-information
#37
JOURNAL ARTICLE
Samuele Buosi, Mohan Timilsina, Maria Torrente, Mariano Provencio, Dirk Fey, Vít Nováček
The recurrence of low-stage lung cancer poses a challenge due to its unpredictable nature and diverse patient responses to treatments. Personalized care and patient outcomes heavily rely on early relapse identification, yet current predictive models, despite their potential, lack comprehensive genetic data. This inadequacy fuels our research focus-integrating specific genetic information, such as pathway scores, into clinical data. Our aim is to refine machine learning models for more precise relapse prediction in early-stage non-small cell lung cancer...
April 3, 2024: Computers in Biology and Medicine
https://read.qxmd.com/read/38608196/applications-of-grounded-theory-methodology-to-investigate-hearing-loss-a-methodological-qualitative-systematic-review-with-developed-guidelines
#38
JOURNAL ARTICLE
Yasmin Ali, Nicola Wright, David Charnock, Helen Henshaw, Haley Morris, Derek J Hoare
OBJECTIVES: Qualitative methodologies are commonly adopted in hearing loss research. Grounded theory methodology is increasingly used to establish novel theories explaining experiences related to hearing loss. Establishing and improving the quality of grounded theory studies has been emphasized as critical to ensuring theoretical trustworthiness. Thus, the primary aim of the present study was to systematically review hearing loss research studies that have applied grounded theory methodology and assess the methodological quality of those grounded theory applications...
May 2024: Ear and Hearing
https://read.qxmd.com/read/38602320/the-hla-i-landscape-confers-prognosis-and-antitumor-immunity-in-breast-cancer
#39
JOURNAL ARTICLE
Xiao-Hong Ding, Yi Xiao, Fenfang Chen, Cheng-Lin Liu, Tong Fu, Zhi-Ming Shao, Yi-Zhou Jiang
Breast cancer is a highly heterogeneous disease with varied subtypes, prognoses and therapeutic responsiveness. Human leukocyte antigen class I (HLA-I) shapes the immunity and thereby influences the outcome of breast cancer. However, the implications of HLA-I variations in breast cancer remain poorly understood. In this study, we established a multiomics cohort of 1156 Chinese breast cancer patients for HLA-I investigation. We calculated four important HLA-I indicators in each individual, including HLA-I expression level, somatic HLA-I loss of heterozygosity (LOH), HLA-I evolutionary divergence (HED) and peptide-binding promiscuity (Pr)...
March 27, 2024: Briefings in Bioinformatics
https://read.qxmd.com/read/38601669/identification-of-cuproptosis-related-mirnas-in-triple-negative-breast-cancer-and-analysis-of-the-mirna-mrna-regulatory-network
#40
JOURNAL ARTICLE
Yitao Wang, Jundan Wang, Jing Jiang, Wei Zhang, Long Sun, Qidong Ge, Chao Li, Xinlin Li, Xujun Li, Shenghong Shi
INTRODUCTION: The close association between cuproptosis and tumor immunity in triple-negative breast cancer (TNBC) allows its monitoring for predicting the prognosis of patients with TNBC. Nevertheless, the biological function and prognostic value of cuproptosis-related miRNAs and their target genes have not been reported. PURPOSE: To construct the miRNA and mRNA-based risk models associated with cuproptosis for patients with TNBC. METHODS: Comparison of expression levels for genes associated with cuproptosis was executed between patients in the normal individuals and the TCGA-TNBC cohort...
April 15, 2024: Heliyon
keyword
keyword
112775
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.